Skip to main content

View full-text article in PMC

. 2016 Nov 17;14(1):157–166. doi: 10.5114/aoms.2016.63739

Table VI.

Haplotypes in the control and epilepsy groups

GABRG2 C588T-GABRG2 INTRON			Patient groups		χ² test p-value, OR, 95% CI
GABRG2 C588T-GABRG2 INTRON			Cases	Controls	χ² test p-value, OR, 95% CI
Haplotypes	CC-AA	N (%)	17 (28.3)	23 (15.0)	Reference
	CC-AG	N (%)	11 (18.3)	43 (28.1)	p = 0.02^*, OR = 0.34, 0.13–0.86
	CC-GG	N (%)	3 (5.0)	13 (8.5)	p = 0.09, OR = 0.31, 0.07–1.27
	CT-AA	N (%)	10 (16.7)	8 (5.3)	p = 0.35, OR = 1.69, 0.55–5.19
	CT-AG	N (%)	5 (8.3)	30 (19.6)	p = 0.007^*, OR = 0.22, 0.07–0.70
	CT-GG	N (%)	9 (15.0)	19 (12.4)	p = 0.38, OR = 0.64, 0.23–1.76
	TT-AA	N (%)	0	7 (4.6)	–
	TT-AG	N (%)	0	5 (3.2)	–
	TT-GG	N (%)	5 (8.3)	5 (3.2)	p = 0.66, OR = 1.35, 0.33–5.42
Total		N (%)	60 (100.0)	153 (100.0)

^*

Statistically significant, OR – odds ratio, CI – confidence interval.